Literature DB >> 25225112

Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: multi-ethnic study of atherosclerosis (MESA).

Joseph Yeboah1, David A Bluemke2, W Gregory Hundley3, Carlos J Rodriguez4, Joao A C Lima5, David M Herrington4.   

Abstract

BACKGROUND: Limited data exist on the association between left ventricular (LV) dilation/remodeling and incident heart failure (HF), especially in adults without prior myocardial infarction (MI) and valvular heart disease. We assessed the association between LV dilation and remodeling and incident HF in a multiethnic cohort. METHODS AND
RESULTS: A total of 4,974 of 6,814 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) had cardiac magnetic resonance imaging and complete data. Kaplan-Meier and Cox proportional hazard analyses were used to assess the association between LV end-diastolic diameter (LVEDD) and adjudicated HF. During the 12 years of follow-up (mean 9.4 y), 177 (3.6%) HF events occurred, 126 (71.2%) in HF with reduced ejection fraction (EF) and 51 (28.8%) in HF with preserved EF. LV dilation (LVEDD >52 mm or >95th percentile) was associated with HF in univariate (hazard ratio [HR] 1.21, 95% confidence interval [CI] 1.08-1.46; P = .007) and multivariable Cox models (HR 1.28, 95% CI 1.09-1.57; P = .01) adjusting for traditional risk factors, medication use, LV EF, and interim MI. We found a significant multiplicative interaction between LVEDD and LV EF in our full multivariable models. Participants with dilated LV and preserved EF had increased risk [HR 2.22, 95% CI 1.46-3.37; P = .006) and those with dilated LV and reduced EF had worse prognosis (HR 7.35, 95% CI 2.36-22.85; P = .0006) compared with normal-size LV and preserved EF. A high proportion of participants with LV dilation had eccentric remodeling, a risk factor for HF. Concentric hypertrophy, also a risk factor for HF, was common in the normal-size LV group.
CONCLUSIONS: LV dilation predicts incident HF independently from risk factors, LV EF, and interim MI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Left ventricular dilation; heart failure; left ventricular ejection fraction; left ventricular remodeling; risk factors

Mesh:

Year:  2014        PMID: 25225112      PMCID: PMC4250423          DOI: 10.1016/j.cardfail.2014.09.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  20 in total

1.  Left ventricular dysfunction: causes, natural history, and hopes for reversal.

Authors:  P W Armstrong
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

Authors:  R S Vasan; M G Larson; E J Benjamin; J C Evans; D Levy
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

3.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

4.  Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard.

Authors:  Johannes Greupner; Elke Zimmermann; Andrea Grohmann; Hans-Peter Dübel; Till F Althoff; Till Althoff; Adrian C Borges; Wolfgang Rutsch; Peter Schlattmann; Bernd Hamm; Marc Dewey
Journal:  J Am Coll Cardiol       Date:  2012-05-22       Impact factor: 24.094

Review 5.  Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment.

Authors:  Marvin A Konstam; Daniel G Kramer; Ayan R Patel; Martin S Maron; James E Udelson
Journal:  JACC Cardiovasc Imaging       Date:  2011-01

6.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

7.  Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis).

Authors:  Carlos J Rodriguez; Ana V Diez-Roux; Andrew Moran; Zhezhen Jin; Richard A Kronmal; Joao Lima; Shunichi Homma; David A Bluemke; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

8.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.

Authors:  Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

9.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

10.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

View more
  15 in total

1.  Normal findings on noninvasive cardiac assessment and the prediction of heart failure: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Stephen T Broughton; Wesley T O'Neal; Mouaz Al-Mallah; David A Bluemke; Susan R Heckbert; Joao A C Lima; Elsayed Z Soliman
Journal:  Int J Cardiol       Date:  2017-12-15       Impact factor: 4.164

2.  Left Ventricular Dilation: When Pediatric Meet Adult Guidelines.

Authors:  Jill Harmon; Kacy Sisco; Marc Dutro; Clifford L Cua
Journal:  Pediatr Cardiol       Date:  2017-09-07       Impact factor: 1.655

3.  Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).

Authors:  Ambarish Pandey; Hassan Khan; Anne B Newman; Edward G Lakatta; Daniel E Forman; Javed Butler; Jarett D Berry
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

4.  Biomass fuel smoke exposure was associated with adverse cardiac remodeling and left ventricular dysfunction in Peru.

Authors:  M S Burroughs Peña; E J Velazquez; J D Rivera; F Alenezi; C Wong; M Grigsby; V G Davila-Roman; R H Gilman; J J Miranda; W Checkley
Journal:  Indoor Air       Date:  2017-01-16       Impact factor: 5.770

Review 5.  New Insights from Major Prospective Cohort Studies with Cardiovascular Magnetic Resonance (CMR).

Authors:  Andrew E Arai
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

6.  Progression of Coronary Artery Calcium and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Hooman Bakhshi; Bharath Ambale-Venkatesh; Xiaoying Yang; Mohammad R Ostovaneh; Colin O Wu; Matthew Budoff; Hossein Bahrami; Nathan D Wong; David A Bluemke; João A C Lima
Journal:  J Am Heart Assoc       Date:  2017-04-20       Impact factor: 5.501

Review 7.  Silent disease progression in clinically stable heart failure.

Authors:  Hani N Sabbah
Journal:  Eur J Heart Fail       Date:  2016-12-14       Impact factor: 15.534

Review 8.  Cardiac structure and function with and without metabolic syndrome: the Echocardiographic Study of Latinos (Echo-SOL).

Authors:  Melissa Burroughs Peña; Katrina Swett; Neil Schneiderman; Daniel M Spevack; Sonia G Ponce; Gregory A Talavera; Mayank M Kansal; Martha L Daviglus; Jianwen Cai; Barry E Hurwitz; Maria M Llabre; Carlos J Rodriguez
Journal:  BMJ Open Diabetes Res Care       Date:  2018-08-13

9.  Genome-Wide Analysis of Left Ventricular Image-Derived Phenotypes Identifies Fourteen Loci Associated With Cardiac Morphogenesis and Heart Failure Development.

Authors:  Nay Aung; Jose D Vargas; Chaojie Yang; Claudia P Cabrera; Helen R Warren; Kenneth Fung; Evan Tzanis; Michael R Barnes; Jerome I Rotter; Kent D Taylor; Ani W Manichaikul; Joao A C Lima; David A Bluemke; Stefan K Piechnik; Stefan Neubauer; Patricia B Munroe; Steffen E Petersen
Journal:  Circulation       Date:  2019-09-25       Impact factor: 29.690

10.  Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.

Authors:  Marta Oknińska; Bouchra El-Hafny-Rahbi; Aleksandra Paterek; Urszula Mackiewicz; Claire Crola-Da Silva; Klaudia Brodaczewska; Michał Mączewski; Claudine Kieda
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.